share_log

ENZON PHARMACEUTICALS INC(ENZN.US)董事增持9.96万股普通股股份,价值约为1.39万美元

The directors of ENZON PHARMACEUTY INC (ENZN.US) increased their common stock holdings by 99,600 shares, worth about US$13,900

Futu News ·  Jun 17, 2023 21:07

On June 17, it was reported that according to the documents disclosed by the US Securities and Exchange Commission (SEC) on June 16,$ENZON PHARMACEUTICALS INC (ENZN.US)$Director READ RANDOLPH C increased its shares of common stock by 99,600 shares at an average price of $0.1,397 per share on June 14 and 16, worth about $13,900.

1687006648763289029.png

What is a statement of change in shareholding?

The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding. When an insider's shareholding changes, depending on different circumstances, it is necessary to submit a statement of change in shareholding to the SEC within a certain period of time after the transaction is completed.

Insiders include the company's directors and executives, as well as any shareholder who owns 10% or more of the company's tradable shares.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment